Correlation Between Iovance Biotherapeutics and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Sarepta Therapeutics, you can compare the effects of market volatilities on Iovance Biotherapeutics and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Sarepta Therapeutics.
Diversification Opportunities for Iovance Biotherapeutics and Sarepta Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Iovance and Sarepta is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Sarepta Therapeutics
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Sarepta Therapeutics. In addition to that, Iovance Biotherapeutics is 2.08 times more volatile than Sarepta Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.15 per unit of volatility. If you would invest 12,159 in Sarepta Therapeutics on November 1, 2024 and sell it today you would lose (714.00) from holding Sarepta Therapeutics or give up 5.87% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Sarepta Therapeutics
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Sarepta Therapeutics |
Iovance Biotherapeutics and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Sarepta Therapeutics
The main advantage of trading using opposite Iovance Biotherapeutics and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |